&nbsp;

no-harm.png

Sep 2024

Drug

nivolumab / relatlimab

Other Name(s): Opdualag™

Quick Link(s): Drug Monograph, Patient Info Sheet

Feb 2025

Regimen

IBRU+RITU

Cancer Type:

Hematologic

Intent: Palliative

Funding:

Exceptional Access Program

iBRUtinib - In Combination with Rituximab for Previously Treated Waldenstrӧms Macroglobulinemia

New Drug Funding Program

Rituximab (Biosimilar IV) and Rituximab SC - In Combination with Ibrutinib for Previously Treated Waldenstrӧms Macroglobulinemia

New Drug Funding Program

Rituximab (Biosimilar IV) and Rituximab SC - In Combination with Ibrutinib for Previously Treated Waldenstrӧms Macroglobulinemia

Drugs Used:

Quick Link(s):

Regimen Monograph

Apr 2025

Regimen

IBRU(MNT)

Cancer Type:

Hematologic,

Lymphoma - Non-Hodgkin's Low Grade

Intent: Palliative

Drugs Used:

iBRUtinib (Unfunded)

Quick Link(s):

Regimen Monograph

May 2025

Regimen

IBRUVENE

Cancer Type:

Hematologic,

Lymphoma - Non-Hodgkin's Low Grade

Intent: Palliative

Drugs Used:

iBRUtinib (Unfunded),

venetoclax (Unfunded)

Quick Link(s):

Regimen Monograph

May 2025

Regimen

NIVL+IPIL

Cancer Type:

Skin,

Melanoma

Intent: Neoadjuvant

Funding:

New Drug Funding Program

Nivolumab plus Ipilimumab - (Neo)adjuvant Resectable Macroscopic Stage III Melanoma

New Drug Funding Program

Nivolumab plus Ipilimumab - (Neo)adjuvant Resectable Macroscopic Stage III Melanoma

Drugs Used:

nivolumab,

ipilimumab

Quick Link(s):

Regimen Monograph

May 2025

Regimen

NIVL

Cancer Type:

Skin,

Melanoma

Intent: Adjuvant

Funding:

New Drug Funding Program

Nivolumab plus Ipilimumab - (Neo)adjuvant Resectable Macroscopic Stage III Melanoma

Drugs Used:

nivolumab

Quick Link(s):

Regimen Monograph

May 2025

Document

ICCU-Cannabis-Poster_AODA.pdf

May 2025

Document

ICCU-Vaping-Poster_AODA.pdf

May 2025

Document

ICCU-Cannabis-Poster-fr_AODA.pdf

May 2025

Document

ICCU-Vaping-Poster_AODA-fr.pdf

May 2025

Document